Pembrolizumab with chemotherapy for adjuvant treatment of newly diagnosed high-risk endometrial cancer after surgery with curative intent [ID6207]

  • In development
  • GID-TA11235
  • Expected publication date: TBC

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6207

Notes